I agree that this site is using cookies. You can find further informations here.
X
Abbott-Banner, Katharine
38  results:
Search for persons X
?
1

Efficacy and safety of a first-in-class inhaled PDE3/4 inhi..:

Bjermer, Leif ; Abbott-Banner, Katharine ; Newman, Kenneth
Pulmonary Pharmacology & Therapeutics.  58 (2019)  - p. 101814 , 2019
Link: https://doi.org/10.1016/..
 
?
2

Neutral sphingomyelinase-2, acid sphingomyelinase, and cera..:

Lea, Simon ; Metcalfe, Hannah ; Plumb, Jonathan...
International Journal of Chronic Obstructive Pulmonary Disease.  11 (2016)  - p. 2139-2147 , 2016
Link: https://doi.org/10.2147/..
 
?
3

The short-term bronchodilator effects of the dual phosphodi..:

Singh, Dave ; Abbott-Banner, Katharine ; Bengtsson, Thomas.
Singh , D , Abbott-Banner , K , Bengtsson , T & Newman , K 2018 , ' The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD ' , European Respiratory Journal , vol. 52 , no. 5 , 1801074 . https://doi.org/10.1183/13993003.01074-2018.  , 2018
Link: https://research.manches..
 
?
4

The short-term bronchodilator effects of the dual phosphodi..:

Singh, Dave ; Abbott-Banner, Katharine ; Bengtsson, Thomas.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214575/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
5

Neutral sphingomyelinase-2, acid sphingomyelinase, and cera..:

Lea, Simon ; Metcalfe, Hannah ; Plumb, Jonathan...
info:eu-repo/semantics/altIdentifier/doi/10.2147/COPD.S95578.  , 2016
Link: https://www.dovepress.co..
 
?
6

Neutral sphingomyelinase-2, acid sphingomyelinase, and cera..:

Lea, Simon R ; Metcalfe, Hannah J ; Plumb, Jonathan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019168/.  , 2016
Link: http://www.ncbi.nlm.nih...
 
?
7

Neutral sphingomyelinase-2, acid sphingomyelinase, and cera..:

Lea, Simon ; Metcalfe, Hannah J ; Plumb, Jonathan...
Lea , S , Metcalfe , H J , Plumb , J , Beerli , C , Poll , C , Singh , D & Abbott-Banner , K H 2016 , ' Neutral sphingomyelinase-2, acid sphingomyelinase, and ceramide levels in COPD patients compared to controls ' , International journal of chronic obstructive pulmonary disease , vol. 11 , no. 1 , pp. 2139-2147 . https://doi.org/10.2147/COPD.S95578.  , 2016
Link: https://research.manches..
 
?
8

Dual PDE3/4 and PDE4 Inhibitors:Novel Treatments For COPD a..:

Abbott-Banner, Katharine H ; Page, Clive P
Abbott-Banner , K H & Page , C P 2014 , ' Dual PDE3/4 and PDE4 Inhibitors : Novel Treatments For COPD and Other Inflammatory Airway Diseases ' , Basic and Clinical Pharmacology and Toxicology , vol. 114 , no. 5 , N/A , pp. 365-376 . https://doi.org/10.1111/bcpt.12209.  , 2014
Link: https://kclpure.kcl.ac.u..
 
?
9

Dual PDE3/4 and PDE4 Inhibitors:Novel Treatments For COPD a..:

Abbott-Banner, Katharine H ; Page, Clive P
Abbott-Banner , K H & Page , C P 2014 , ' Dual PDE3/4 and PDE4 Inhibitors : Novel Treatments For COPD and Other Inflammatory Airway Diseases ' , Basic and Clinical Pharmacology and Toxicology , vol. 114 , no. 5 , N/A , pp. 365-376 . https://doi.org/10.1111/bcpt.12209.  , 2014
Link: https://kclpure.kcl.ac.u..
 
?
10

Proceedings of the Twenty-second Biennial Council of Pi Lam..:

PARKER, MARJORIE H. ; WILES, MARION E. ; ALPENFELS, ETHEL...
Educational Horizons.  40 (1961)  1 - p. 2-115 , 1961
Link: https://www.jstor.org/st..
 
?
11

Proceedings of the Twenty-first Biennial Council of Pi Lamb..:

Rose, Muriel Anderson ; SCHARER, NORMAN B. ; HARDY, GEORGIANA...
Educational Horizons.  38 (1959)  1 - p. 2-109 , 1959
Link: https://www.jstor.org/st..
 
?
12

Development of a Once-Daily Modified-Release Formulation fo..:

Tompson, Debra ; Whitaker, Mark ; Pan, Rennan...
Pharmaceutical Research.  39 (2022)  1 - p. 153-165 , 2022
Link: https://doi.org/10.1007/..
 
?
13

A randomised, placebo-controlled study of RIPK1 inhibitor G..:

Weisel, Kathy ; Scott, Nicola ; Berger, Scott...
BMJ Open Gastroenterology.  8 (2021)  1 - p. e000680 , 2021
Link: https://doi.org/10.1136/..
 
?
14

Development of a Prototype, Once-Daily, Modified-Release Fo..:

Tompson, Debra J. ; Whitaker, Mark ; Pan, Rennan...
Pharmaceutical Research.  38 (2021)  7 - p. 1235-1245 , 2021
Link: https://doi.org/10.1007/..
 
?
15

Cyclic nucleotide phosphodiesterase inhibitors as therapeut..:

Turner, Mark J. ; Abbott-Banner, Kathy ; Thomas, David Y..
Pharmacology & Therapeutics.  224 (2021)  - p. 107826 , 2021
Link: https://doi.org/10.1016/..
 
1-15